Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018 od Ashleigh McGirr, Shehzad M. Iqbal, Jan Olbrecht, Lijoy Varghese

Preuzmi cijeli tekst

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future od Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge Gomez, Lijoy Varghese, Sharon Zhang

Preuzmi cijeli tekst

Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines od Beatriz Quiambao, Lijoy Varghese, Nadia Demarteau, Ruth Faye Sengson, Jenaline Javier, Piyali Mukherjee, Leah Cheryl Manio, Scott Preiss

Preuzmi cijeli tekst

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany od Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber, Anastassia Anastassopoulou

Preuzmi cijeli tekst

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old od Desirée Van Oorschot, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Lijoy Varghese, Alfred von Krempelhuber, Mohamed Neine, Stéphane Lorenc, Desmond Curran

Preuzmi cijeli tekst